Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Harold Swerdlow, George Komatsoulis, Juli Klemm, Daniel Bradbury, Robert Epstein, More

Premium

The New York Genome Center has appointed Harold Swerdlow as vice president of technology innovation. He joins NYGC from the Wellcome Trust Sanger Institute, where he was head of R&D. Prior to that, he was chief technology officer at Dolomite and senior director of research at Solexa.


George Komatsoulis has left the National Cancer Institute to work as a senior bioinformatics specialist at the National Center for Biotechnology Information.

Previously, he was the deputy director of the NCI's Center for Biomedical Informatics and
Information Technology (CBIIT). He's also served as acting chief information officer and interim director for CBIIT.

Juli Klemm is serving as acting deputy director for CBIIT while the agency searches for a replacement.


Illumina stockholders voted to re-elect four members of its board of directors, approving three-year terms on the board for Daniel Bradbury, Robert Epstein, and Roy Whitfield, and a two-year term for Francis deSouza.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.